Projects at Oslo University Hospital

	Project status	Project leader		Project name	Type of study	Ethics approval	Biobank
1	Ongoing	Anne Hege Aamodt	Division of Clinical Neuroscience	The Norwegian NeuroCOVID study	Multicenter prospective observational study	Conditional approval	Own collection
2	Ongoing	Hanne Birgit Alfheim	Division of Emergencies and Critical Care	Corona virus-related visitation restrictions enforced in ICUs in the Scandinavian countries – what can we learn to meet future challenges?	Survey	N/A	No
3	Ongoing	Erik Koldberg Amundsen	Division of Laboratory Medicine	Laboratory diagnostics for risk stratification in COVID-19	Observational study. Laboratory based study	Approved	Own collection
4	Ongoing	Anders Åsberg	Division of Surgery, Inflammatory Diseases and Transplantation	COVID-19 outcome in patients with chronic kidney disease	Epidemiological study, registry study, Diagnostic/Prognostic study	Approved	Other biobank
5	Ongoing	Anders Åsberg	Division of Surgery, Inflammatory Diseases and Transplantation	Pharmacokinetic population analysis of antiviral drugs in the NOR SOLIDARITY study	Pharmacokinetic population modelling	Conditional approval	Own collection
6	Ongoing	Andreas Barratt-Due Pål Aukrust Anne Ma Dyrhol Riise	Division of Emergencies and Critical Care Division of Surgery, Inflammatory Diseases and Transplantation Division of Medicine	WHO: The NOR Solidarity multicenter trial on the efficacy of different anti-viral drugs in SARS CoV-2 infected patients Clinical Trials.gov	Multicenter prospective clinical trial	Approved	Own collection
7	Ongoing	Andreas Barratt-Due	Division of Emergencies and Critical Care	Veno-venous ECMO-treatment of patients with COVID-ARDS	Quality study	N/A	No
8	Ongoing	Kristin Bjordal Cecilie Delphin Amdal	Oslo Hospital Service Division of Cancer Medicine	Development of an international questionnaire to assess patient-reported symptoms and concerns related to COVID-19 disease, the COVID-19 QLQ-##	Questionnaire development	Approved	No
9	Ongoing	Atle Bjørnerud	Division of Radiology and Nuclear Medicine	Artificial intelligence to quantify important segments from CT in COVID-19	Innovation	Under revision	No
10	Ongoing	Elisabeth Bø	Division of Medicine	Physiotherapy treatment of hospitalised patients with COVID-19 at Oslo University Hospital	Health service research	N/A	No
11	Ongoing	Arne Broch Brantsæter	Division of Medicine	Development of an antibody reference standards for COVID-19	Collection of plasma samples for vaccine development	Conditional approval	Own collection
12	Ongoing	Michael Bretthauer Mette Kalager	Division of Surgery, Inflammatory Diseases and Transplantation	Rapid-Cycle Re-Implementation of TRAining Facilities in Norway (TRAiN study)	Observational study	Approved	No
13	Ongoing	John Arne Dahl	Division of Laboratory Medicine	PREDCOV	Observational study	Approved	Yes
14	Ongoing	Veselka Petrova Dimova-Svetoslavova	Division of Laboratory Medicine	Establishment of Interferon-gamma-analysis for accurate detection of SARS-CoV-2 T-cell response	Basic research	N/A	No
15	Ongoing	Lars Eide	Division of Laboratory Medicine	COVID-19 general biobank	General research biobank	Approved	COVID-19 general biobank
16	Ongoing	Ane Gerda Z Eriksson	Division of Cancer Medicine	Influence of the COVID-19 pandemic on women with gynecological cancer	Quality study	N/A	No
17	Ongoing	Stig Evensen	Division of Mental Health and Addiction	COPSYC-19: Consequences for patients with psychosis from the SARS-CoV-2 shut-down	Observational study and patient survey	Approved	No
18	Ongoing	Ann Færden	Division of Mental Health and Addiction	The COVID-19 pandemic: Reactions of acutely ill psychiatric patients	Quality study	N/A	No
19	Ongoing	Ann Færden	Division of Mental Health and Addiction	The COVID-19 pandemic: reactions from mental health workers in the acute psychiatric department	Quality study	N/A	No
20	Ongoing	Yngvar Fløisand Hanne Scholz	Division of Cancer Medicine Division of Surgery, Inflammatory Diseases and Transplantation	Decidual stromal cells (DSC) in treatment of COVID-19 induced respiratory failure	Clinical trial	Conditional approval	Own collection
21	Ongoing	Tine Kristin Grimholt	Division of Medicine	COVID-19 and reactions in the Norwegian population	Survey	Approved	No
22	Ongoing	Tine Kristin Grimholt	Division of Medicine	Mental reactions to COVID-19 among adults with heart failure	Survey	Approved	No
23	Ongoing	Gunnveig Grødeland	Division of Laboratory Medicine	Novel vaccine development against COVID-19	Innovation project	N/A	No
24	Ongoing	Jostein Skjalg Hagemo	Prehospital Services	Prehospital treatment of "silent hypoxia" in young patients COVID-19	Case series	Conditional approval	No
25	Ongoing	Ansgar Heck	Division of Medicine	COVID-19 in patients with pituitary disease	Multicenter observational study	Conditional approval	Own collection
26	Ongoing	Åslaug Helland	Division of Cancer	SARS-CoV-2 and Cancer	Epidemiological observational study	Approved	No
27	Ongoing	Fridtjof Heyerdahl	Prehospital Services	Inhaled NO as a bridge to rapid sequence intubation in COVID-19 related hypoxemia (INOCOV-19)	Randomized Controlled Trial	Conditional approval	No
28	Ongoing	Kristin Hofsø	Division of Emergencies and Critical Care	Survival rates and long-term outcomes for patients with COVID-19 admitted to Norwegian ICUs	Multicenter observational study	Approved	No
29	Ongoing	Aleksander Rygh Holten	Division of Medicine	VHP + 1836: EU-SolidAct - Baricitinib. A randomized, controlled multicenter study of hospitalized COVID-19 patients	Randomized Controlled Trial	Approved	No
30	Ongoing	Jan Cato Holter, Susanne Dudman Anne Ma Dyrhol-Riise Aleksander Rygh Holten	Division of Laboratory Medicine Division of Medicine	Norwegian SARS-CoV-2 study Clinicaltrials.gov	Multicenter observational study	Approved	Own collection
31	Ongoing	Eivind Hovig	Division of Cancer Medicine	Production of "in house" versions of reverse transcriptase and Taq DNA polymerase for use in SARS-CoV-2 assays	Innovation project	N/A	No
32	Ongoing	Håvard Kalvøy	Oslo Hospital Service	Splitting one ventilator for multiple patients	Technical assessment	N/A	No
33	Ongoing	Tom Hemming Karlsen	Division of Surgery, Inflammatory Diseases and Transplantation	Genetic risk for severe lung affection during COVID-19	Case-control association study	Conditional approval	COVID-19 general biobank
34	Ongoing	Arne Kolstad	Division of Cancer Medicine	Monitoring of immunological response to COVID-19 vaccine in lymphoma/leukemia patients treated with anti-CD20 monoclonal antibodies and in patients who have completed allogenic stem cell transplantation	Observational study	Conditional approval	Own collection
35	Ongoing	Maria Stylianou Korsnes	Division of Mental Health and Addiction	COVID-19 impact on patient care	Quality study	N/A	No
36	Ongoing	Elfrida Hartveit Kvarstein Geir Pedersen	Division of Mental Health and Addiction	Vulnerable patients with personality disorder - consequences of the corona crisis	Cross sectional, multi-center survey	Approved	No
37	Ongoing	Nina M. Kynø	Division of Paediatric and Adolescent Medicine	Pandemic 2020 - Parental debut in isolation	Survey	N/A	No
38	Ongoing	Jon Henrik Laake	Division of Emergencies and Critical Care	Handling oxygenation targets in adults with COVID-19 associated acute hypoxaemic respiratory failure in the ICU	Multicenter clinical trial	Approved	No
39	Ongoing	Irene Lie	Division of Cardiovascular and Pulmonary Diseases	A Norwegian study on views and experiences of health care professions working in intensive care units during the COVID-19 pandemic	Multicenter cohort and focus group interview study	Conditional approval	No
40	Ongoing	Tom Mala	Division of Surgery, Inflammatory Diseases and Transplantation	Abdominal pain in COVID-19 patients	Case reports	Conditional approval	No
41	Ongoing	Karsten Midtvedt	Division of Surgery, Inflammatory Diseases and Transplantation	COVID IgG KTx	Multicenter observational study	Conditional approval	Own collection
42	Ongoing	Karsten Midtvedt	Division of Surgery, Inflammatory Diseases and Transplantation	SARS-CoV-2 Immune KTx-study	Multicenter observational study	Approved	Own collection
43	Ongoing	Peter Monrad-Hansen	Division of Emergencies and Critical Care	Acute appendicitis at Oslo University Hospital before and after Covid-19 restrictions: Business as usual or delay?	Quality study	N/A	No
44	Ongoing	Bjørn Moum	Division of Medicine	Secure IBD registry. Surveillance epidemiology of Coronavirus (COVID-19) under research exclusion.	Quality study	N/A	No
45	Ongoing	Ludvig Munthe	Division of Laboratory Medicine	Defining the immune cells that correlate with fatal acute lung injury in COVID-19	Epidemiological pathogenetic study		COVID-19 general biobank
46	Ongoing	Ludvig Munthe	Division of Laboratory Medicine	Establishing in tube-diagnostic tests for immunity or susceptibility for SARS-CoV-2 in elderly cancer patients and in high-risk children	Innovation project	N/A	No
47	Ongoing	Lise Sofie Nissen-Meyer	Division of Laboratory Medicine	Convalescent plasma therapy for patients with severe COVID-19	Clinical trial	Conditional approval	COVID-19 general biobank
48	Ongoing	Lise Sofie Nissen-Meyer	Division of Laboratory Medicine	NORPLASMA monitor	Observational study	Conditional approval	No
49	Ongoing	Lise Sofie Nissen-Meyer	Division of Laboratory Medicine	Antibody screening in blood donors	Observational study	Approved	COVID-19 general biobank
50	Ongoing	Lise Sofie Nissen-Meyer	Division of Laboratory Medicine	Novel antibodies against HLA1	Observational study	N/A	COVID-19 general biobank
51	Ongoing	Ingvild Nordøy	Division of Surgery, Inflammatory Diseases and Transplantation	Superinfections in Covid-19 patients in the ICU - before and after dexamethasone	National multicenter retrospective observational study	Approved	No
52	Ongoing	Randi Opheim	Division of Medicine	Views of patients with inflammatory bowel disease on the COVID-19 pandemic and the health care service	Quality study	N/A	No
53	Ongoing	Karl Øyri	Division of Emergencies and Critical Care	Research and Development for a low-cost, quickly produced mechanical ventilator capacity scaling system for COVID-19 affected communities	Technical assessment	N/A	No
54	Ongoing	Frank Olav Pettersen	Division of Medicine	SARS-CoV-2 antibody screening in health care professionals at OUS	Quality study	N/A	No
55	Ongoing	Frank Olav Pettersen	Division of Medicine	SARS-CoV-2 among hospital staff at Oslo University Hospital	Quality study	N/A	No
56	Ongoing	Frank Olav Pettersen	Division of Medicine	Incidence and characteristics of SARS-CoV-2 immune response among first line COVID-19 hospital staff	Observational study	Approved	COVID-19 general biobank
57	Ongoing	Søren Pischke	Division of Emergencies and Critical Care Division of Laboratory Medicine	Prevalence of complement activation in COVID-19 patients admitted to OUS	Quality study	N/A	No
58	Ongoing	Marius Rehn	Prehospital Services	Pre-hospital management of COVID-19	Quality study	N/A	No
59	Ongoing	Kristin Lie Romm	Division of Mental Health and Addiction	REACT-NOR - react now! Remote follow-up of relatives of patients with psychosis during the COVID-19 crisis	Health service research	N/A	No
60	Ongoing	Kristin Lie Romm	Division of Mental Health and Addiction	COPE - Corona pandemic experiences by patients with psychotic - and bipolar disorders	Survey	Approved	No
61	Ongoing	Ellen Ruud	Division of Paediatric and Adolescent Medicine	Effect of the COVID19 pandemic on pediatric cancer incidence at Oslo University Hospital	Quality study	N/A	No
62	Ongoing	Nina Haagenrud Schultz	Division of Cancer Medicine	Venous thrombosis after COVID-19 vaccines	Observational study	Conditional approval	Own collection
63	Ongoing	Nina Haagenrud Schultz	Division of Cancer Medicine	Do COVID-19 vaccines lead to increased coagulation ability?	Observational study	Conditional approval	Own collection
64	Ongoing	Andreas Seierstad	Division of Mental Health and Addiction	COVID-19 and labor market participation for young adults with psychosis	Observational study	N/A	No
65	Ongoing	Vasilis Sitras	Division of Paediatric and Adolescent Medicine	COVID-19 in Pregnancy, Childbirth and Puerperium (COVID-Preg-ChiP Study)	Observational study with survey	Conditional approval	Own collection
66	Ongoing	Anne Lee Solevåg	Division of Paediatric and Adolescent Medicine	Visitor bans in hospitals: How are newborn infants affected during the COVID-19 pandemic?	Observational study with survey	Conditional approval	Own collection
67	Ongoing	Arne Vasli Søraas	Division of Laboratory Medicine	Risk factors for community- and workplace transmission of COVID-19 Clinical Trials.gov	Epidemiological observational study	Approved	No
68	Ongoing	Arne Vasli Søraas	Division of Laboratory Medicine	Cod Liver Oil for COVID-19 Prevention Study	Non-clinical interventional study	Approved	Other biobank
69	Ongoing	Ketil Størdal	Division of Paediatric and Adolescent Medicine	COVID-19 and children in BEREDT-C19	Epidemiological study	N/A	No
70	Ongoing	Kjetil Sunde	Division of Emergencies and Critical Care	Intensive medicine priority decisions during the COVID-19 pandemic (INTENSIVE TRIAGE)	Prospective multicentre observational study	Approved	No
71	Ongoing	Kjetil Taskén	Division of Cancer Medicine	Immunoregulatory and antiviral properties of compounds derived from anti-malaria drugs as hydroxychloroquine	Explorative preclinical drug development	N/A	No
72	Ongoing	Kjetil Taskén	Division of Cancer Medicine	Aminoacridines with dual SARS-CoV2 antiviral and immunostimulating activity	Explorative preclinical drug development	N/A	No
73	Ongoing	Suraj Bahadur Thapa	Division of Mental Health and Addiction	Psychological distress and Coping in Psychiatric Patients during COVID-19 pandemic (PsyCo-COVID-19): A cross-sectional study at Oslo University Hospital	Survey	Conditional approval	No
74	Ongoing	Kirsti Tøien	Division of Emergencies and Critical Care	Visiting restrain to hospitals; family caregivers of COVID-19 ICU-patients experiences. An exploratory study	Survey	N/A	No
75	Ongoing	Kristian Tonby Theresa Olasveengen Aleksander Rygh Holten	Division of Medicine Division of Emergencies and Critical Care Division of Medicine	COVID-19 OUS. Kvalitetsregister for alle pasienter innlagt ved Oslo Universitetssykehus med COVID-19 sykdom.	Quality study	N/A	No
76	Ongoing	Kristian Tonby	Division of Medicine	Korona-screen	Quality study	N/A	No
77	Ongoing	Kristian Tonby	Division of Medicine	Treatment of hospitalized COVID-19 – A randomized multicenter study (Discovery)	Clinical trial	Approved	No
78	Ongoing	Margrethe von Tangen	Division of Emergencies and Critical Care	Retrospektiv vurdering av triagering av Covid-19 pasienter ved bruk av nytt Kap 41: Mistanke om Corona-infeksjon	Quality study	N/A	No
79	Ongoing	Lars Wik	Prehospital Services	Sensor based vital signs monitoring of patients with clinical manifestation of COVID-19 disease during home isolation	Randomized feasibility study	Conditional approval	No